Monosacáridos

N-Cyclohexylpropyl deoxynorjirimycin is a sugar that belongs to the group of carbohydrates. It is an analog of deoxynojirimycin and has been synthesized by glycosylation, methylation, and fluorination of the natural product. N-Cyclohexylpropyl deoxynorjirimycin can be used as an intermediate for the synthesis of other carbohydrate compounds.

6-Amino-6-deoxy-D-galactopyranose HCl is a sugar that is synthesized by the modification of 6-amino-6-deoxygalactose with hydrochloric acid. It is used as an intermediate in the synthesis of complex carbohydrates, polysaccharides and oligosaccharides. 6-Amino-6-deoxygalactose HCL has been modified to introduce fluorine atoms at different positions. This chemical compound has been shown to have antimicrobial activity against methicillin resistant Staphylococcus aureus (MRSA) in vitro, but not against other bacterial strains tested.

1-S-Phenyl-2-O-acetyl-3,4-di-O-benzyl-a-L-thiorhamnopyranose is a fluorinated monosaccharide. It is a custom synthesis that is an oligosaccharide with complex carbohydrate. The sugar has been modified by glycosylation and polysaccharide. It also has click modification and methylation. 1-S-Phenyl-2-O-acetyl -3,4 di O benzyl a L thiorhamnopyranose is the CAS No. 636559 71 2. This product is high purity, making it suitable for industrial applications such as pharmaceuticals, agrochemicals, and cosmetics.

4-Methylphenyl 1-thio-2,3,4,6-tetra-O-(trimethylsilyl)-b-D-glucopyranoside is a carbohydrate that can be made in custom synthesis. This product is a high purity and has a CAS number of 942043-17-6. The chemical name for this product is 4-(methylphenyl)-1-[(trimethylsilyl)oxy]-2,3,4,6-tetra‑O‑benzoyl--b‑D‑glucopyranoside. It has been fluorinated and methylated.

4-Aminophenyl 2,3,4,6-tetra-O-acetyl-a-D-mannopyranoside is a modified oligosaccharide that has been synthesized by the glycosylation of methylated 4-aminophenol with 1,2,3,5-tetra-O-(acetyl)-D-mannitol. The acetyl group at the sixth position on the mannose residue is introduced by acetic anhydride. The chemical formula for this compound is C10H11NO7 and it has a molecular weight of 285.24 g/mol. This compound was tested for its ability to inhibit bacterial growth in vitro and found to be active against E. coli and S. aureus (ATCC 25923).

Benzyl 2,3,4-tri-O-acetyl-4-nitromethyl-b-D-arabinopyranose is a water soluble, white solid that is a glycosylation product of Benzyl 2,3,4-tri-O-acetyl b D arabinopyranose and 4 nitrobenzaldehyde. It can be used for the modification of polysaccharides and as an intermediate in the synthesis of oligosaccharides. This compound has been shown to be effective in inhibiting the growth of Mycobacterium tuberculosis and Mycobacterium avium complex.

Benzyl 4,6-O-benzylidene-b-D-glucopyranoside is a synthetic monosaccharide. It is an oligosaccharide that has undergone glycosylation and polysaccharide modifications. Benzyl 4,6-O-benzylidene-b-D-glucopyranoside can be used for the preparation of various carbohydrates with customized structures. This product can be synthesized in high purity.

8-Methoxycarbonyloctyl 2-deoxy-2-phthalimido-b-D-glucopyranoside is a glycoconjugate that is used as an anti-tumor agent. It is a synthetic glycosaminoglycan with a polysaccharide backbone and fluorinated saccharide branches. The monosaccharides are linked by methylene bridges, and the oligosaccharides are modified with methoxycarbonyl groups. This compound has been shown to have activity against tumor cells in vitro and in vivo, and it may be useful for the treatment of cancer. 8-Methoxycarbonyloctyl 2-deoxy-2-phthalimido-b-D-glucopyranoside can be synthesized on request.

2,6-Di-O-acetyl-3,4-di-O-benzyl-a-D-mannopyranosyl trichloroactimidate is a synthetic, glycosylate sugar that can be used in the synthesis of oligosaccharides and polysaccharides. This molecule has been fluorinated to increase its lipophilicity and stability. It has been modified with methyl groups to improve its reactivity with other molecules. The purity of 2,6-Di-O-acetyl-3,4-di-O-benzyl-a-D-mannopyranosyl trichloroactimidate is greater than 98%.

(2S- trans)-4-Hydroxy-N-methyl 2-pyrrolidinecarboxamide is a modification of the sugar molecule. It is a complex carbohydrate that belongs to the group of oligosaccharides. It has CAS number 143035-54-5 and can be synthesized in high purity with a glycosylation process. This chemical can also be fluorinated and saccharide substituted to create a wide range of products with different properties.

4-Iodophenyl 2-acetamido-2-deoxy-b-D-glucopyranoside is a modification of an oligosaccharide. It is synthesized using custom chemistry and purified to high purity. This compound is a monosaccharide that is methylated and glycosylated. CAS No. 38229-81-1

1,3,5-Tri-O-acetyl-2-deoxy-b-D-ribofuranose is a sugar that is an antioxidant. It has significant antioxidant activity in the presence of hydrogen peroxide, and is also a potent inhibitor of lipid peroxidation. 1,3,5-Tri-O-acetyl-2-deoxy-b-D-ribofuranose has been shown to have antiviral properties against influenza A virus and cytomegalovirus. The antiviral activity may be due to its ability to inhibit viral RNA synthesis and block the glycosidic bond between the nucleotide base and ribose sugar. This sugar is used as an analytical method for measuring molecular weight (MW) by nmr spectra. The molecular formula for 1,3,5 triacetyl 2 deoxy b D ribofuranose is C6H12O7 or CH2OHCHOCH2COOH.

Phenyl 2-O-benzyl-a-L-thiorhamnopyranoside (PTBP) is a synthetic glycosylation product. It is used as a monosaccharide building block for oligosaccharides and polysaccharides. PTBP exhibits high purity, custom synthesis capability, and is available in bulk quantities.

1,3,4,6-Tetra-O-acetyl-2-deoxy-2-N-phthalimido-a-D-glucopyranose is a synthetic carbohydrate with a high purity and custom synthesis. This compound is a sugar that can be modified to glycosylation or methylation for the desired application. It is used as a building block for the synthesis of oligosaccharides, monosaccharides, and complex carbohydrates.

17b-Estradiol 3-O-benzyl 17-(2,3,4-tri-O-acetyl-b-D-glucuronide methyl ester) is a modification of estradiol with an attached sugar. It is synthesized from the carbohydrate complex oligosaccharide. The synthesis starts by attaching an acetyl group to the sugar at the 3 position and then reacting it with benzyl alcohol to form a glycosidic linkage. The synthesis ends with a fluorination and saccharide cleavage.

The 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-galactopyranosyl-(N-Fmoc)-L-serine pentafluorophenyl ester is a synthetic sugar that has been modified using the Click chemistry. It is a complex carbohydrate that can be used in the synthesis of oligosaccharides and polysaccharides. This product is custom synthesized to order and has high purity. The 2AA3TA2DO6TFA2DGA2DGAPFPE2SAR2LSE5 is an oligosaccharide with a monosaccharide at the reducing end and methylated at the nonreducing end. The 2AA3TA2DO6TFA2DGA2DGAPFPE2SAR2LSE5 has been fluorinated at the saccharide position on the nonreducing end

2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-b-D-galactopyranosyl)-L-threonine is a custom synthesis. It is modified with fluorination and methylation. This product is an oligosaccharide with saccharide, CAS No., and polysaccharide. It has glycosylation and sugar which are carbohydrates. The complex carbohydrate can be found in a variety of sources such as corn syrup, honey, molasses, soybean oil, etc.

Propranolol is a drug that belongs to the class of beta blockers, which are used to control high blood pressure in women and neonates. Propranolol is metabolized by glucuronidation and hydroxylation into 4'-hydroxypropranolol-4'-O-b-D-glucuronide. The hydroxy group on propranolol is metabolized by hydroxylation in the liver. This metabolic pathway leads to the formation of 4'-hydroxypropranolol-4'-O-b-D-glucuronide, which is excreted through urine samples and plasma concentrations. The hydroxy group on propranolol is also metabolized by glucuronidation, leading to the formation of low bioavailability of propranolol in humans. Propranolol has been shown to inhibit platelet aggregation at higher doses, but its effects on platelet aggregation are not predictable at lower doses.

Cell-permeable sialic acid analog